Search research articles
Contact Us
Filters
Showing results (71-80 of 122) with videos related to
Page
of 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 16, 2011
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer
Maria Q Baggstrom, Yingwei Qi, Marianna Koczywas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Phase I dendritic cell p53 peptide vaccine for head and neck cancer
Patrick J Schuler, Malgorzata Harasymczuk, Carmen Visus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib
Mary J Fidler, Athanassios Argiris, Jyoti D Patel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 5, 2023
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Ayesha S Ali, Gregor Manukian, Jennifer M Johnson, et al.
Head & Neck
|
February 2, 2011
Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy
Trevor M Feinstein, Stephen Y Lai, Diana Lenzner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck
Michael T Milano, Daniel J Haraf, Kerstin M Stenson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2005
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy
Michael T Milano, Everett E Vokes, Joseph K Salama, et al.
Head & Neck
|
May 28, 2016
Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma
Jessica L Geiger, Julie E Bauman, Michael K Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2011
XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck
Alec Vaezi, Xiaozhe Wang, Shama Buch, et al.
The Laryngoscope
|
December 20, 2007
Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer
Athanassios Argiris, Michalis V Karamouzis, Jonas T Johnson, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 122) with videos related to
Sort By:
Page
of 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 16, 2011
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer
Maria Q Baggstrom, Yingwei Qi, Marianna Koczywas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Phase I dendritic cell p53 peptide vaccine for head and neck cancer
Patrick J Schuler, Malgorzata Harasymczuk, Carmen Visus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib
Mary J Fidler, Athanassios Argiris, Jyoti D Patel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 5, 2023
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Ayesha S Ali, Gregor Manukian, Jennifer M Johnson, et al.
Head & Neck
|
February 2, 2011
Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy
Trevor M Feinstein, Stephen Y Lai, Diana Lenzner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck
Michael T Milano, Daniel J Haraf, Kerstin M Stenson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2005
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy
Michael T Milano, Everett E Vokes, Joseph K Salama, et al.
Head & Neck
|
May 28, 2016
Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma
Jessica L Geiger, Julie E Bauman, Michael K Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2011
XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck
Alec Vaezi, Xiaozhe Wang, Shama Buch, et al.
The Laryngoscope
|
December 20, 2007
Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer
Athanassios Argiris, Michalis V Karamouzis, Jonas T Johnson, et al.
Page
of 13